NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
11.68
+0.05 (0.43%)
Dec 18, 2025, 4:00 PM EST - Market closed
NeoGenomics Employees
NeoGenomics had 2,200 employees as of December 31, 2024. The number of employees increased by 100 or 4.76% compared to the previous year.
Employees
2,200
Change (1Y)
100
Growth (1Y)
4.76%
Revenue / Employee
$322,346
Profits / Employee
-$51,576
Market Cap
1.51B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,200 | 100 | 4.76% |
| Dec 31, 2023 | 2,100 | 0 | - |
| Dec 31, 2022 | 2,100 | 100 | 5.00% |
| Dec 31, 2021 | 2,000 | 300 | 17.65% |
| Dec 31, 2020 | 1,700 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NEO News
- 3 days ago - NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation - Business Wire
- 8 days ago - NeoGenomics to Present New ctDNA Research at SABCS 2025 - Business Wire
- 10 days ago - NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025 - Business Wire
- 4 weeks ago - Neo Performance Materials Inc. (NEO:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - NeoGenomics to Participate in Upcoming Investor Conferences - Business Wire
- 7 weeks ago - NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors - Business Wire
- 7 weeks ago - NeoGenomics, Inc. (NEO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - NeoGenomics Reports Third Quarter 2025 Results - Business Wire